Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection-Reference-Cited by-同舟云学术

Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection

Published:2023-11 Issue:5 Volume:116 Page:1020-1027
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Zhou Nicolas^ORCID,Niu Jiangong,Nelson David,Feldman Hope A.,Antonoff Mara B.,Hofstetter Wayne L.,Mehran Reza J.,Rice David C.,Sepesi Boris,Swisher Stephen G.,Walsh Garret L.,Giordano Sharon H.,Rajaram Ravi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference27 articles.

1. Trends and geographic patterns in drug and synthetic opioid overdose deaths–United States, 2013-2019;Mattson;MMWR Morb Mortal Wkly Rep,2021

2. Adult cancer pain;Swarm;J Natl Compr Canc Netw,2013

3. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline;Paice;J Clin Oncol,2016

4. Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain;Posternak;Pain,2016

5. Risks of developing persistent opioid use after major surgery;Soneji;JAMA Surg,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer;Journal of Surgical Oncology;2024-09-10

2. The Surgical Renaissance: Advancements in Video-Assisted Thoracoscopic Surgery and Robotic-Assisted Thoracic Surgery and Their Impact on Patient Outcomes;Cancers;2024-09-05

3. Prevalence and risk factors for persistent opioid use after thoracic surgery: a retrospective cohort study using claims data in a prefecture of Japan;2024-09-02

4. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients;International Immunopharmacology;2024-03